Investigation of Epigenetic Dysregulation in Lupus NK Cells
狼疮 NK 细胞表观遗传失调的研究
基本信息
- 批准号:10194280
- 负责人:
- 金额:$ 23.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-03-03 至 2023-02-28
- 项目状态:已结题
- 来源:
- 关键词:AffectAntigen-Antibody ComplexAtlasesBenchmarkingBiologicalBiological AssayBlood donorCell Adhesion MoleculesCell CompartmentationCell physiologyCell surfaceCell-Mediated CytolysisCellsCellular biologyChIP-seqCharacteristicsChromatinClinicalClinical ResearchComplexCytometryDNA MethylationDNA Sequence AlterationDataData SetDevelopmentDiseaseEpigenetic ProcessFluorescence-Activated Cell SortingFoundationsFrequenciesFunctional disorderFutureGeneticGenomicsGoalsGranzymeHeterogeneityHistone AcetylationHistone DeacetylaseHistonesImmuneImmune ToleranceImmune responseImmune systemIndividualInterferon Type IIInterventionInvestigationLightLinkLupusLysineMHC Class I GenesMeasuresMediatingMethodsModelingMolecularMonitorMonozygotic twinsNK Cell ActivationNatural Killer CellsOther GeneticsOutcomePathologicPatientsPatternPeripheral Blood Mononuclear CellPharmaceutical PreparationsPharmacologyPhenotypePlayPopulationProductionProteomicsReceptor CellRefractoryRegulationResolutionRoleSamplingSystemic Lupus ErythematosusTNF geneTechnologyTestingTherapeutic InterventionTransposaseVirus DiseasesVorinostatantibody-dependent cell cytotoxicitybaseclinically significantcytokinecytotoxicitydisease heterogeneitydisorder riskepigenetic markerepigenetic variationepigenomicsgenomic locushealthy volunteerhigh dimensionalityhigh rewardhigh riskhistone modificationhuman diseaseimmune functionindexinginnovationinsightnovelnovel therapeuticsperforinperipheral bloodreceptorsingle cell analysissingle cell technologysystemic inflammatory response
项目摘要
PROJECT SUMMARY
The overarching goal of this proposal is to systematically characterize an epigenetically distinct natural
killer (NK) cell population with hypoacetylated histones. This NK cell subset is reduced in frequency in systemic
lupus erythematosus (SLE) patients with increased disease activity. We will test the hypothesis that this NK cell
subset, which we term “NKSLE cells”, has a distinct cell surface molecule profile, and is functionally different from
other NK cells in cytolytic capacity and cytokine secretion upon activation. We will further examine if NK cell
functions can be altered by experimental manipulation of histone acetylation. Our data will lay a strong foundation
for future epigenomic studies on specific genes or genomic loci pivotal for lupus pathophysiology. The advent of
single-cell technologies has greatly accelerated our understanding of immune system heterogeneity. Increasing
evidence supports a compelling model in which pathologically important cells in SLE may represent only a small
fraction of the highly complex immune system. This proposal builds upon this innovative concept, and will
leverage cutting-edge technologies to interrogate the epigenetic and proteomic heterogeneity of NK cells, and
their complex relationships. In Aim 1, we will employ highly multiplexed mass cytometry to monitor a broad array
of functionally important NK cell markers, such as activating and inhibitory receptors, cell adhesion molecules,
and those indicative of cytotoxicity activity, and histone acetylation abundance in individual NK cells. We will first
benchmark NK cell heterogeneity in healthy blood donors, with a goal to identify cellular features associated with
global histone acetylation level. Next, we will extend the analysis to SLE patients, whose NK cell compartments
show reduced representation of cells with hypoacetylated histones. This study will reveal the phenotypic and
functional characteristics of NKSLE cells. In Aim 2, we will investigate the functional differences between NK cells
with differential histone acetylation content. Cytotoxicity and proinflammatory cytokine secretion are key
immunological functions mediated by NK cells during a viral infection. Mass cytometry will be utilized to examine
how differential histone acetylation abundance in individual NK cells is correlated with the degree of their immune
response upon activation measured by degranulation markers, and cytokine production. Our analysis will first
focus on NK cells isolated from healthy volunteers, and subsequently extend to those from lupus patients to
better understand the clinical significance of NKSLE cell reduction in lupus. Lastly, as opposed to genetic
mutations that are generally refractory to therapeutic interventions, epigenetic phenomena are largely reversible,
making them attractive targets for developing new drugs. We will investigate the plasticity of NK cell functions
by pharmacologically manipulating histone acetylation. Together, our proposal will provide new insights into the
biological and pathological significance of histone acetylation in NK cell molecular and functional phenotypes.
Our data will be valuable for future studies on lupus and other human diseases in which NK cells play important
pathological roles.
项目摘要
该提案的总体目标是系统地表征表观遗传上不同的自然
杀手级(NK)细胞群含有低乙酰化组蛋白。该NK细胞子集的全身性频率降低
狼疮性红斑患者(SLE)患者疾病活性增加。我们将测试这个NK细胞的假设
我们称其为“ nksle细胞”的子集具有不同的细胞表面分子曲线,并且在功能上不同
激活后,其他NK细胞以细胞溶解能力和细胞因子分泌。我们将进一步检查NK细胞是否
通过对组蛋白乙酰化的实验操纵可以改变功能。我们的数据将奠定坚实的基础
对于未来的表观基因组学研究,有关狼疮病理生理学的特定基因或基因组基因组关键。冒险
单细胞技术极大地加速了我们对免疫系统异质性的理解。增加
证据支持一个引人注目的模型,在该模型中,SLE中重要的重要细胞可能仅代表一个小的
高度复杂的免疫系统的一部分。该提议建立在这个创新的概念的基础上,并将
利用尖端技术来询问NK细胞的表观遗传和蛋白质组学异质性,以及
他们复杂的关系。在AIM 1中,我们将采用高度多路复用的质量细胞仪来监视宽阵列
功能上重要的NK细胞标记物(例如激活和抑制受体),细胞粘附分子,
以及指示细胞毒性活性以及各个NK细胞中组蛋白乙酰化丰度的那些。我们将首先
健康献血者的基准NK细胞异质性,目的是识别与细胞特征相关的细胞特征
全球组蛋白乙酰化水平。接下来,我们将将分析扩展到SLE患者,其NK细胞室的患者
表现出降低的用乙酰化组蛋白的细胞表示。这项研究将揭示表型和
NKSLE细胞的功能特征。在AIM 2中,我们将研究NK细胞之间的功能差异
具有差异性组蛋白乙酰化含量。细胞毒性和促炎性细胞因子分泌是关键
NK细胞在病毒感染过程中介导的免疫功能。质量细胞仪将用于检查
单个NK细胞中的差异组蛋白乙酰化丰度如何与免疫的程度相关
通过脱粒标记和细胞因子产生测量激活后的反应。我们的分析将首先
专注于从健康志愿者中分离出的NK细胞,随后扩展到狼疮患者到
更好地了解狼疮中NKSLE细胞降低的临床意义。最后,与遗传相反
通常对热干预的突变,表观遗传现象在很大程度上是可逆的,
使它们成为开发新药的有吸引力的目标。我们将研究NK细胞功能的可塑性
通过药物操纵组蛋白乙酰化。一起,我们的建议将为您提供新的见解
组蛋白乙酰化在NK细胞分子和功能表型中的生物学和病理学意义。
我们的数据对于将来对NK细胞发挥重要作用的狼疮和其他人类疾病的研究很有价值
病理角色。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PAUL JOSEPH UTZ其他文献
PAUL JOSEPH UTZ的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PAUL JOSEPH UTZ', 18)}}的其他基金
Epigenetic Histone Landscape Profiles in HIV
HIV 中的表观遗传组蛋白景观谱
- 批准号:
10535173 - 财政年份:2022
- 资助金额:
$ 23.63万 - 项目类别:
Investigation of Epigenetic Dysregulation in Lupus NK Cells
狼疮 NK 细胞表观遗传失调的研究
- 批准号:
10363743 - 财政年份:2021
- 资助金额:
$ 23.63万 - 项目类别:
Giant MagnetoResistive (GMR) Sensors for Measuring Influenza Vaccine
用于测量流感疫苗的巨磁阻 (GMR) 传感器
- 批准号:
10317652 - 财政年份:2020
- 资助金额:
$ 23.63万 - 项目类别:
Giant MagnetoResistive (GMR) Sensors for Measuring Influenza Vaccine
用于测量流感疫苗的巨磁阻 (GMR) 传感器
- 批准号:
9975682 - 财政年份:2016
- 资助金额:
$ 23.63万 - 项目类别:
Giant MagnetoResistive (GMR) Sensors for Measuring Influenza Vaccine
用于测量流感疫苗的巨磁阻 (GMR) 传感器
- 批准号:
9753117 - 财政年份:2016
- 资助金额:
$ 23.63万 - 项目类别:
Giant MagnetoResistive (GMR) Sensors for Measuring Influenza Vaccine
用于测量流感疫苗的巨磁阻 (GMR) 传感器
- 批准号:
9539943 - 财政年份:2016
- 资助金额:
$ 23.63万 - 项目类别:
ACE: Autoimmunity Center of Excellence (ACE) at Stanford
ACE:斯坦福大学自身免疫卓越中心 (ACE)
- 批准号:
8680545 - 财政年份:2014
- 资助金额:
$ 23.63万 - 项目类别:
ACE: Autoimmunity Center of Excellence (ACE) at Stanford
ACE:斯坦福大学自身免疫卓越中心 (ACE)
- 批准号:
9266354 - 财政年份:2014
- 资助金额:
$ 23.63万 - 项目类别:
Measuring Influenza and H1N1 vaccine responses in immunodeficient patients
测量免疫缺陷患者的流感和 H1N1 疫苗反应
- 批准号:
8306395 - 财政年份:2011
- 资助金额:
$ 23.63万 - 项目类别:
Th17 lymphocytes in human autoimmune diseases
Th17淋巴细胞在人类自身免疫性疾病中的作用
- 批准号:
7688799 - 财政年份:2009
- 资助金额:
$ 23.63万 - 项目类别:
相似国自然基金
CD147分子促侵袭表位的确认及基于抗原抗体复合物结构的新型抗肿瘤多肽设计
- 批准号:
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
抑制性受体TIGIT高亲和力抗体的结构基础
- 批准号:U1732109
- 批准年份:2017
- 资助金额:66.0 万元
- 项目类别:联合基金项目
针对绿脓杆菌三型毒性分泌系统关键调控蛋白spuE的抗体开发及机理研究
- 批准号:31771006
- 批准年份:2017
- 资助金额:60.0 万元
- 项目类别:面上项目
人乳头瘤病毒样颗粒不同中和表位的特性与结构基础研究
- 批准号:81471934
- 批准年份:2014
- 资助金额:72.0 万元
- 项目类别:面上项目
优化氰基类拟除虫菊酯农药残留筛查免疫分析方法的基础研究
- 批准号:30771425
- 批准年份:2007
- 资助金额:32.0 万元
- 项目类别:面上项目
相似海外基金
Dissecting the heterogeneity and function of myeloid cells in lupus nephritis
剖析狼疮性肾炎骨髓细胞的异质性和功能
- 批准号:
10588862 - 财政年份:2023
- 资助金额:
$ 23.63万 - 项目类别:
"Lnc"ing XIST Ribonucleoprotein Particles to Female Sex-Attributed Biases in Autoimmunity
“Lnc”ing XIST 核糖核蛋白颗粒对自身免疫中女性性别归因的偏见
- 批准号:
10525045 - 财政年份:2022
- 资助金额:
$ 23.63万 - 项目类别:
"Lnc"ing XIST Ribonucleoprotein Particles to Female Sex-Attributed Biases in Autoimmunity
“Lnc”ing XIST 核糖核蛋白颗粒对自身免疫中女性性别归因的偏见
- 批准号:
10707968 - 财政年份:2022
- 资助金额:
$ 23.63万 - 项目类别:
Investigation of Epigenetic Dysregulation in Lupus NK Cells
狼疮 NK 细胞表观遗传失调的研究
- 批准号:
10363743 - 财政年份:2021
- 资助金额:
$ 23.63万 - 项目类别:
High-throughput mapping of antigen specificity to B-cell-receptor sequence for characterizing antibody responses in HIV-vaccinated and infected individuals
B 细胞受体序列抗原特异性的高通量图谱,用于表征 HIV 疫苗接种者和感染者的抗体反应
- 批准号:
10478203 - 财政年份:2020
- 资助金额:
$ 23.63万 - 项目类别: